Achieve Clinical Research Announces COPD Research Studies in Birmingham, Alabama
Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for those already diagnosed with COPD.
- Birmingham, AL (1888PressRelease) September 24, 2011 - "Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with COPD," says Hayes Williams, MD, PhD., the Medical Director and Principal Investigator at Achieve Clinical Research since 2001. "Treatments for COPD are one of the research studies we are pleased to continue with at Achieve Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans."
The research studies will enroll those already diagnosed with COPD, which includes symptoms like a chronic cough, shortness of breath (dyspnea), and frequent respiratory infections. More advanced symptoms include cyanosis, which is bluish discoloration of the lips and nail beds due to a lack of oxygen in blood, morning headaches due to an inability to remove carbon dioxide from the blood, unusual weight loss, and coughing up blood. In order to participate in the studies, volunteers must already be diagnosed with COPD.
Achieve Clinical Research will not take volunteers who:
Have any evidence or treatment of malignancy within the previous 5 years
Have a history of alcohol or substance abuse within the previous 5 years
Have used an investigatory medicine or participated in an investigatory study within 30 days of the screening
Achieve Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. Achieve is currently enrolling adults aged 18-75 for two, separate COPD studies in Birmingham, AL. For more information regarding participation in our research studies, contact Achieve Clinical Research at 205.757.8208, or at www.AchieveClinical.com.